High plasma levels of 8-methoxypsoralen following bath water delivery in dermatological patients

Skin Pharmacology and Applied Skin Physiology

Volumn 16, Issue 5, 2003, Pages 305-312

  Kappes, U P ^a   Barta, U ^a   Merkel, U ^a   Balogh, A ^a   Elsner, P ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

8 Methoxypsoralen; Bath PUVA therapy; Bioavailability; Pharmacokinetic profile

Indexed keywords

METHOXSALEN;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ATOPIC DERMATITIS; BALNEOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; GRANULOMA ANNULARE; HUMAN; LICHEN PLANUS; MALE; MORPHEA; PRIORITY JOURNAL; PSORIASIS VULGARIS; PUVA; SKIN DISEASE;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BATHS; BIOLOGICAL AVAILABILITY; FEMALE; HALF-LIFE; HUMANS; MALE; METHOXSALEN; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PUVA THERAPY; SKIN ABSORPTION; SKIN DISEASES; TIME FACTORS; WATER;

EID: 0042573881     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072070     Document Type: Article

References (20)

1. Röcken M, Kerscher M, Volkenandt M, Plewig G: Balneophototherapie. Hautarzt 1995;46:437-450.
2. Halpern SM, Anstey AV, Dawe RS, Diffey BL, Farr PM, Ferguson J, Hawk JLM, Ibbotson S, McGregor JMM, Murphy GM, Thomas SE: Guidelines for topical PUVA: A report of a workshop of the British Photodermatology Group. Br J Dermatol 2000;142:22-31.
3. Lüftl M, Degitz K, Plewig G, Röcken M: Psoralen bath plus UVA therapy. Arch Dermatol 1997;133:1597-1603.
4. Kerscher M, Lehmann P: PUVA-Bad-Photochemotherapie: Geschichtlicher Überblick, Ergebnisse einer Umfrage und therapeutische Richtlinien. Akt Dermatol 1996;22:252-255.
5. von Kobyletzki G, Hoffmann K, Kerscher M, Altmeyer P: Plasma levels of 8-methoxypsoralen following PUVA-bath photochemotherapy. Photodermatol Photoimmunol Photomed 1998;14:136-138.
6. Fischer T, Hartvig P, Bondesson U: Plasma concentrations after bath treatment and oral administration of trioxsalen. Acta Derm Venereol 1980;60:177-179.
7. Thomas SE, O'Sullivan J, Balac N: Plasma levels of 8-methoxypsoralen following oral or bath-water treatment. Br J Dermatol 1991;125:56-58.
8. Gomez MI, Azana JM, Arranz I, Harto A, Ledo A: Plasma levels of 8-methoxypsoralen after bath-PUVA for psoriasis: Relationship to disease severity. Br J Dermatol 1995;133:37-40.
9. Fredriksson T, Pettersson U: Severe psoriasis - Oral therapy with a new retinoid. Dermatologica 1978;157:238-244.
10. Stalder JF, Taïeb A: Severity scoring of atopic dermatitis: The SCORAD index. Consensus report of the European task force on atopic dermatitis. Dermatology 1993;186:23-31.
11. Balogh A, Merkel U, Looks A, Vollandt R, Wollina U: Drug monitoring of orally administered 8-methoxypsoralen in patients treated with extracorporeal photopheresis. Skin Pharmacol Appl Skin Physiol 1998;11:258-265.
12. Susato F, Humfild S, Reinauer H, Mesching R: High performance liquid chromatography measurement of 8-methoxypsoralen in plasma. Chromatographia 1986;21:443-446.
13. Gazith J, Schalla W, Bauer E, Schaefer H: 8-Methoxypsoralen (8-MOP) in human skin: Penetration kinetics. J Invest Dermatol 1978;71:126-130.
14. Pham CT, Koo JY: Plasma levels of 8-methoxypsoralen after topical paint PUVA. J Am Acad Dermatol 1993;28:460-466.
15. Huuskonen H, Koulu L, Wilen G: Quantitative determination of methoxalen in human serum, suction blister fluid and epidermis by gas chromatography mass spectrometry. Photodermatology 1984;1:137-140.
16. Vallat VP, Gilleaudeau P, Battat L, Wolfe J, Nabeya R, Heftler N, Hodak E, Gottlieb AB, Krueger JG: PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: A possible cellular basis for remittive therapy. J Exp Med 1994;180:283-296.
17. Kammerau B, Klebe U, Zesch A, Schaefer H: Penetration, permeation, and resorption of 8-methoxypsoralen: Comparative in vitro and in vivo studies after topical application of four standard preparations. Arch Dermatol Res 1976;255:31-42.
18. Neild VS, Scott LV: Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralen. Br J Dermatol 1982;106:199-203.
19. David M, Lowe NJ, Halder RM, Borok M: Serum 8-methoxypsoralen (8-MOP) concentrations after bath water delivery of 8-MOP plus UVA. J Am Acad Dermatol 1990;23:931-932.
20. von Kobyletzki G, Gruss C, Altmeyer P, Kerscher M: Balneophotochemotherapie des Lichen ruber. Hautarzt 1997;48:323-327.